Mestag SRL
The score of Mestag shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -44 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mestag's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −15,026 € | ||||
| Equity | −91,454 € | ||||
| Cash | 2,793 € | ||||
| EBITDA | −13,875 € | ||||
| Total assets | 31,077 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Sep 2026
- Year ended 31 Dec 2024filed on 04 Sep 2026
- Year ended 31 Dec 2023filed on 17 Jul 2024
- Year ended 31 Dec 2022filed on 27 Sep 2023
- Year ended 31 Dec 2021filed on 04 Oct 2022
Mestag's financial analysis
- Solvency-294.3%sector median: 40.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mestag
Mestag's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0843.124.889
- VAT number
- BE0843124889
- Peppol
- Registered · 0208:0843124889 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Jan 2012
- Registered office
- 1083 Ganshoren
- Latest accounts
- 2025 · filed on 09 Sep 2026
- Activity
- Manufacture of irradiation, electromedical and electrotherapeutic equipment (NACE 26600)
Mestag (SRL) has been based in Ganshoren since 2012, active in: manufacture of irradiation, electromedical and electrotherapeutic equipment. For 2025, it reports a net loss of 15,026 € and equity of −91,454 €; its revenue is not published. Its solvency stands at -294.3%, below the median of its sector (40.8%).
Companies similar to Mestag
Companies in the same business, of comparable size and area, outside its group.
- Centre Auditif Chairi Retail sale of medical and orthopaedic goods Berchem-Sainte-Agathe · balance sheet 103,650 €
- Evoluson Retail sale of medical and orthopaedic goods Forest · balance sheet 421,971 €
- Grand Audition SPA Manufacture of irradiation, electromedical and electrotherapeutic equipment Spa · balance sheet 127,360 €
- Acutus Medical Manufacture of medical and dental instruments and supplies Antwerp · balance sheet 379,830 €
- Medical Electronic Systems Europe Wholesale of pharmaceutical and medical goods Fleurus · balance sheet 776,419 €
- Audinc Belgium Manufacture of irradiation, electromedical and electrotherapeutic equipment Essen · balance sheet 37,444 €
- Demant Belgium Manufacture of irradiation, electromedical and electrotherapeutic equipment Leuven · balance sheet €8.81m
- Bioncise Manufacture of medical and dental instruments and supplies Wellen · balance sheet 242,768 €
Frequently asked questions about Mestag
What is the revenue of Mestag?
Mestag files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mestag?
In Belgium, the VAT number is the company number prefixed with BE: BE0843124889 for Mestag, if the company is VAT-registered. Its company number (CBE) is 0843.124.889.
Where is the registered office of Mestag?
According to the CBE register, the registered office of Mestag is in 1083 Ganshoren.
What is the equity of Mestag?
At the close of the 2025 financial year, the equity of Mestag amounts to -91,454 €, a solvency of -294.3% of total assets.
Who manages Mestag?
The register lists 1 active mandates at Mestag. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mestag
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →